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Abstract 
Background & Aims: Irritable bowel syndrome (IBS) is associated with significant disease burden and 
decreased quality of life (QOL). We investigated the effects of IBS on different areas of daily function 
and compared these among disease subtypes. 
Methods: The Life with IBS survey was conducted by Gfk Public Affairs & Corporate Communications 
from September through October 2015. Respondents met Rome III criteria for constipation-
predominant or diarrhea-predominant IBS (IBS-C and IBS-D, respectively). Data were collected from 
3254 individuals (mean age, 47 years; 81% female; and 90% Caucasian) who met IBS criteria. 
Results: Respondents who were employed or in school (n=1885) reported that IBS symptoms affected 
their productivity an average of 8.0 days out of the month and they missed approximately 1.5 days of 
work/school per month because of IBS. More than half the individuals reported that their symptoms 
were very bothersome. Individuals with IBS-C were more likely than with IBS-D to report avoiding sex, 
difficulty concentrating, and feeling self-conscious. Individuals with IBS-D reported more avoidance of 
places without bathrooms, difficulty making plans, avoiding leaving the house, and reluctance to travel. 
These differences remained when controlling for symptom bothersomeness, age, sex, and employment 
status. In exchange for 1 month of relief from IBS, more than half of the sample reported they would be 
willing to give up caffeine or alcohol, 40% would give up sex, 24.5% would give up cell phones, and 
21.5% would give up the internet for 1 month. 
Conclusions: Although the perceived effects of IBS symptoms on productivity are similar among its 
subtypes, patients with IBS-C and IBS-D report differences in specific areas of daily function. 
KEY WORDS:  abdominal pain; daily living; absenteeism; presenteeism 
Introduction 
Irritable Bowel Syndrome (IBS) is associated with significant disease burden. Many studies have 
documented decreased quality of life1–3, elevated rates of psychological comorbidities4,5, and high 
economic costs associated with IBS6.  For example, patients with IBS have been reported to have worse 
health-related quality of life than patients with diabetes or end-stage renal disease1 and up to 38% of 
individuals with IBS report having contemplated suicide as a result of their symptoms7.  
The impact of IBS on daily functioning has been quantified primarily in studies of workplace 
absenteeism and presenteeism (lost productivity at work). In a survey mailed to households in the 
United States, individuals with IBS reported missing an average of 13.4 days of work or school per year, 
compared to 4.9 days for those without IBS8.  A recent survey study reported that 24% of respondents 
had missed work in the last week due to IBS symptoms and 87% had experienced reduced productivity 
at work in the same time period9.  Another study has estimated nearly 14 hours per week of lost 
productivity due to IBS in a 40-hour work week10. 
Only a small number of studies have evaluated the impact of IBS on other aspects of daily living 
such as social interactions, relationships with friends/family, and activities outside the home. The first to 
report the impact of IBS across domains of daily living was a survey of 42 patients seen in  tertiary care 
facilities, which outlined avoidance of activities such as exercise, work, household chores, socializing, 
travel, leisure, eating, and sexual intercourse11. That study reported that IBS patients were significantly 
more likely to avoid daily activities when symptoms were present, with over 40% of the sample 
reporting avoidance in each category when symptomatic. Another study using an online research survey 
of individuals in the community meeting Rome III criteria for IBS found that over 50% of the sample 
reported impairment in each domain of daily living, with higher rates of impairment reported by 
individuals who also met criteria for depression, anxiety, or panic disorders12. Two large survey studies, 
one in the United States and one in Europe, measuring the impact of IBS on daily life also reported high 
rates of impairment in domains such as eating outside the home, going out with friends, traveling, and 
going to new or unfamiliar places13,14.  However, these studies have not distinguished between IBS 
subtypes.  Only one prior study has approximated differences in impairment between IBS subtypes using 
subscales of a validated quality of life (QOL) questionnaire 15. That study reported lower overall QOL in 
diarrhea-predominant IBS (IBS-D [n=56]) compared to constipation-predominant IBS (IBS-C [n=54]), with 
significantly lower average scores in food avoidance, social reaction, and relationships subscales in IBS-
D. However, no study to date has compared impairment of specific daily activities in IBS subtypes using a 
large, nationwide sample of individuals in the community with IBS-C and IBS-D. 
Methods 
Study survey 
Data from the “Life with IBS” survey was analyzed for this research study. This was an online 
(emailed) survey conducted for the American Gastroenterological Association by GfK Public Affairs & 
Corporate Communications (GfK) with the financial support of Ironwood Pharmaceuticals, Inc. and 
Allergan plc. in September and October of 2015. The objective of the survey was to explore the attitudes 
of IBS sufferers, and to better understand their experiences living with IBS. Participants were recruited 
from a national sample (all 50 states) of Gfk ‘s large database of individuals in the United States. At 
initial recruitment into the database, participants provide information about their habits, health 
conditions, and other areas of interest, which is then used to select individuals for specific surveys. Gfk 
provides a modest incentive as well as opportunities to enter raffles and sweepstakes in order to 
encourage participation in their surveys and to foster member loyalty. Members receive approximately 
1 emailed survey per week related to a variety of topics, with email and telephone reminders if the 
survey is not completed. Detailed information about GfK’s survey methodology is available elsewhere16. 
To be considered eligible for this study, respondents had to meet Rome III criteria for IBS-C or 
IBS-D. Respondents were excluded if they met criteria for IBS-M, or if they reported having been 
diagnosed with ulcerative colitis, Crohn’s disease, celiac disease, colon cancer, stomach cancer or other 
cancer of the gastrointestinal tract.  
Survey items were developed based on input from a team of physicians and researchers with 
expertise in the diagnosis and treatment of IBS. The median survey response length was 17 minutes. The 
survey assessed the impact of IBS on specific activities of daily living using the questions shown in table 
1. These questions inquired about number of days per month of missed work/school; reduced 
productivity at work/school; and interference with ability to participate in personal activities. Next, the 
questions asked respondents to rate how much they agreed with statements about the impact of IBS on 
other areas of living (e.g. feeling self-conscious about body image; avoiding sex; difficulty planning 
activities; problems traveling; spending less time with family/friends; avoiding situations without easily 
accessible bathrooms) using a 4-point scale: 1= “strongly disagree”; 2= “somewhat disagree”; 3= 
“somewhat agree”; 4 = “strongly agree”.  Finally, respondents were asked to identify “trade-offs” (i.e. 
what they would be willing to give up) in exchange for 1 month of hypothetical symptom relief. For 
these questions, they indicated “yes” or “no” regarding willingness to give up each item or activity. The 
list of possible trade-offs is provided in table 1. Respondents were also asked about gastrointestinal 
symptoms experienced in the last 12 months and how bothersome overall gastrointestinal symptoms 
were on a 5-point scale (1=not at all bothersome; 2=a little bothersome; 3=somewhat bothersome; 
4=very bothersome; 5=extremely bothersome).  
Demographic data included age (years), sex, race, highest education level; marital status, 
median income, and employment status (employed, self-employed, temporarily unemployed, full-time 
student; full-time homemaker, retired). For our analyses, we considered respondents who were 
employed, self-employed, or full-time students to be “employed”. 
Statistics 
Continuous variables were summarized using means and standard deviations, while categorical 
variables were expressed as proportions. Comparisons of proportions were made using Chi square test 
for discrete outcomes, and continuous outcomes were compared using T test for pairwise comparisons.  
Respondents were considered to have avoided or been impaired in a specific daily activity if they rated 
their agreement as “strongly agree” or “somewhat agree”.  
 Multivariate logistic regression was used to identify factors associated with each of the twelve 
areas of reported impairment. Variables included in these models included: IBS subtype, age, 
employment status (employed/not employed), sex, and bothersomeness of symptoms (rated on the 5-
point scale described above). All of the variables of interest were included in a single logistic model to 
provide mutually adjusted estimates of the odds ratio (with 95% confidence interval (CI)) for the 
likelihood of reporting each area of impairment.  We accounted for multiple comparisons using the 
Bonferroni correction and an alpha level for statistical significance of 0.004. 
Results 
Sample 
In total, 3,254 people (1,587 with IBS-D; 1667 with IBS-C) completed the questionnaires. The 
majority (81%) was female and Caucasian (90%). The mean age was 47.32 years (SD 15.14). Table 2 
provides detailed demographics. The most commonly experienced symptom in both IBS-C and IBS-D was 
abdominal pain, with 84% of IBS-C and 93% of IBS-D respondents reporting having experienced the 
symptom in the last 12 months (table 3). Almost all (>99%) reported their gastrointestinal symptoms to 
be at least a little bothersome. More than half (53% IBS-C, 50% IBS-D) considered their symptoms to be 
at least very bothersome. There was no statistical significance in degree of bothersomeness of IBS 
symptoms between subtypes (Figure 1).  
Impact on daily activities 
Productivity. Of the respondents who reported being currently employed or currently in school 
(n=1,885), 36% reported that IBS symptoms impacted their productivity at work or school at least 10 
days out of the month (average=8.0 days/month, SD=8.1). There were no statistically significant 
differences between IBS-C and IBS-D in terms of impact on productivity: 37% of employed respondents 
with IBS-C and 35% of employed respondents with IBS-D reported that symptoms impacted productivity 
10 or more days per month (IBS-C: average=8.2 days (SD=8.4); IBS-D: average=7.7 days (SD=7.7). Of all 
employed respondents, 15.4% reported that IBS did not impact productivity at all (16.2% in IBS-C and 
14.5% in IBS-D). 
Days missed from work or school. Data on number of days missed from work or school in a 
typical month were available from 1,497 respondents (out of 1,885 who were employed or in school). 
IBS-D reported missing approximately 1.3 days of work/school per month while IBS-C reported missing 
an average of 1.7 days per month (p=0.032). Over half of the employed respondents (56%) reported 
missing no days of work/school due to IBS symptoms in a typical month (IBS-C=58%, IBS-D=55%); 38% of 
the sample reported missing between 1 and 5 days of work/school in a typical month (IBS-C=35%; IBS-
D=40%); 4% reported missing between 6 and 10 days of work/school in a typical month (IBS-C=5%; IBS-
D=3%, p=NS); and about 2% reported missing more than 10 days of work/school per month (IBS-C=2%; 
IBS-D=2%, p=NS). 
Participation in personal activities. When asked how often their IBS symptoms interfere with 
personal activities (e.g. parties, sporting events, family activities, etc.), 34% of both IBS-C and IBS-D 
reported that symptoms interfered at least 10 days per month.  
Specific activities. Respondents across subtypes reported a significant negative impact of IBS 
symptoms on overall daily functioning (Figure 2). For example, more than half the individuals reported 
their symptoms prevented them from enjoying daily activities, traveling more often, and feeling 
successful.  Similarly, both subtypes reported avoiding situations where there would not be a bathroom, 
making social plans, leaving the house, and having sex. IBS also made the majority of individuals feel 
“not normal” and/or “self-conscious”.  
 There were significant differences between subtypes of IBS in several activities of daily life 
(Figure 2). Respondents with IBS-C were more likely than IBS-D to report avoiding sex, feeling self-
conscious about body image, have difficulty concentrating, and feeling “not like myself” as a result of 
their symptoms (p < 0.004 for all comparisons). Respondents with IBS-D reported more avoidance of 
places without bathrooms, difficulty making plans, avoiding leaving the house, and traveling less than 
respondents with IBS-C (p < 0.004 for all comparisons).   
Multivariable analysis. In separate multivariable logistic regressions predicting reported 
difficulty in each specific area of life and controlling for subtype (IBS-C vs. IBS-D), employment status 
(employed/student vs. unemployed), age, sex (male/female), and symptom bothersomeness, the sub-
type differences shown in figure 2 remained significant.  Namely, in multivariable analyses respondents 
with IBS-C were significantly more likely than IBS-D to report avoiding sex, feeling self-conscious, having 
difficulty concentrating, and feeling “not like myself”. Respondents with IBS-C were significantly less 
likely than IBS-D to report avoidance of places without bathrooms, difficulty making plans, avoiding 
leaving the house, and traveling less as a result of their symptoms (see supplementary table 1).  
In addition, being employed/student was independently associated with lower likelihood of 
difficulty making plans outside of the home, avoiding leaving the house, problems enjoying daily 
activities, and problems traveling. Older age was associated with lower likelihood of reporting difficulty 
leaving the house, avoiding sex, difficulty reaching one’s ‘full potential’, difficulty concentrating on tasks, 
feeling ‘not normal’, and feeling self-conscious. Higher symptom bothersomeness was significantly 
associated with difficulty with each domain. Finally, sex differences were noted in 5 of the domains, with 
women being more likely to report avoiding sex, feeling self-conscious about their bodies, and feeling 
“not like myself”. Women were less likely than men to report avoiding travel, avoiding spending time 
with family/friends, and difficulty concentrating due to symptoms. Univariate analyses are available in 
supplementary table 2. 
Trade-Offs. In response to the hypothetical question “What, if anything, would you give up for 
one month to experience one month of relief from your gastrointestinal symptoms?” over half the 
sample reported that they would be willing to give up alcohol or caffeine, 40% would give up sex for one 
month, while 25% would give up their cell phone and 22% the internet (Figure 3). IBS-D participants 
were generally more willing to give up daily conveniences than IBS-C, although the only significant 
difference between subtypes was in the IBS-D group’s willingness to give up caffeine. 
Discussion 
 The results of this survey reveal that, although IBS-C and IBS-D are equally bothersome (>50% 
describing IBS as “very” or “extremely” bothersome), and were associated with similar levels of 
absenteeism/presenteeism, they impact specific areas of daily living in different ways. IBS-D was 
associated with more avoidance of activities outside of the home (e.g. travel, making plans, leaving the 
house, going places without easily accessible bathrooms), which remained significant even when 
controlling for age, sex, employment status, and symptom bothersomeness. IBS-C, on the other hand, 
was associated with more interpersonal impairment (e.g. feeling self-conscious, avoiding sex, difficulty 
concentrating), which also remained significant when controlling for the above-mentioned factors. 
Our finding that individuals with IBS-D are more likely to avoid specific activities outside the 
home, especially those without easily accessible bathrooms (e.g. traveling), can likely be explained by 
symptoms such as increased bowel frequency and/or urgency. On the other hand, the finding that 
individuals with IBS-C are more likely to internalize their distress (e.g. feel self-conscious about body 
image) and to avoid physical intimacy likely has both physiologic and psychological explanations. For 
example, higher rates of avoidance of sex in IBS-C may be related to the frequently encountered pelvic 
floor symptom distress such as pelvic organ prolapse and lower urinary tract symptoms, residual stool in 
the pelvic colon and rectum, or co-existing pelvic floor tension myalgia syndrome17. Psychologically, 
avoidance of sex in IBS-C may be impacted by our finding that IBS-C respondents reported feeling more 
self-conscious about their body image. There is compelling literature identifying the interference of IBS 
on sexual relationships, but this literature has not distinguished between subtypes.  In one study of 
women with IBS, 77% reported significant sexual dysfunction compared to 29% with IBD and 14% with 
duodenal ulcers20. In another study of both men and women, 43% reported significant sexual 
dysfunction, including decreased sex-drive and dyspareunia21.   
Similarly, higher rates of feeling self-conscious about body image in IBS-C compared to IBS-D 
may be related to symptoms of bloating and distension that are commonly reported in IBS-C. Although 
there is some data to suggest that individuals with IBS have lower self-esteem and poorer coping 
strategies compared to healthy controls20, differences between subtypes have not been evaluated. 
Responses to a hypothetical question asking what respondents would be willing to give up in 
exchange for one month of symptom relief provides insight into the distress caused by IBS symptoms. 
For example, 25% of the sample reported willingness to give up their cell phone for one month and 22% 
reported willingness to give up the internet.  40% reported willingness to give up sex for 1 month 
(although this may be inflated by those who are already avoiding sex due to symptoms) and over half of 
the sample reported that they would give up alcohol or caffeine for one month in exchange for 
symptom relief. There were no statistically significant differences between IBS subtypes here, except 
that IBS-D was more likely to give up caffeine compared to IBS-C, which may reflect dietary restrictions 
that are already in place for individuals with IBS-D. These findings are in line with other published data 
regarding what individuals with IBS might be willing to trade for symptom relief. For example, two 
separate studies have reported that individuals with IBS would be willing to give up an average of 15 
years of their life in exchange for permanent symptom relief21,22. 
Notably, there were no differences between subtypes in number of days per month of reduced 
productivity at work/school, number of days per month absent from work/school, or number of days 
with reduced participation in personal activities. In our sample, 36% of those who were employed or 
enrolled in school (n=1,885) reported that IBS symptoms impacted their productivity at work or school 
at least 10 days out of the month (average 8.0 days/month), with an average of 1.5 days of missed work 
or school per month. This rate of absenteeism is somewhat higher than a previous report of individuals 
with IBS missing an average of 13.4 days of work/school per year8, but the overall high rates of 
presenteeism and absenteeism due to IBS symptoms is consistent with the literature8–10 
 This study highlights important differences between IBS-C and IBS-D, which could impact the 
development and refinement of mind-body therapies for IBS, with tailored treatment goals for each IBS 
subtype. For example, treatment tailored specifically for IBS-D may be more behaviorally focused (e.g. 
exposure to specific situations outside the home) while treatment for IBS-C may be more cognitively 
focused (e.g. evaluating self-esteem and beliefs about self and others) in addition to targeting the bowel 
dysfunction and pain.  
 This study has several strengths including its large sample size, inclusion of individuals from the 
community rather than tertiary centers, and ability to compare IBS subtypes. However, there are also 
several limitations. First, only IBS-C and IBS-D respondents were included and we were not able to 
evaluate the daily burden of IBS mixed type.  Second, because this was an online survey, respondents 
were included based on self-report of IBS (using Rome criteria), and were not evaluated by a 
gastroenterologist or through evaluation of medical records. There is also the possibility of sampling and 
recall bias due to the online survey design. Third, this survey did not specifically assess the influence of 
other medical or psychiatric comorbidities on overall impairment of daily living and did not include a 
healthy or “non-IBS” control group for comparison. Fourth, at the time that this survey was conducted, 
there was no available validated measure of impairment in daily living for IBS and, as a result, the survey 
questions here did not use a validated measure. Finally, although this data was obtained from 
respondents in all 50 states, the sample is not representative of the national population in terms of 
demographic distribution. 
 In summary, results of this large survey-based study suggest that, although the perceived 
bothersomeness of IBS symptoms and reported rates of absenteeism/presenteeism are similar between 
IBS-D and IBS-C subtypes, individuals with IBS-C and IBS-D report differences in specific areas of daily 
functioning. Understanding these differences will be important in developing effective strategies for 
managing the effects of IBS symptoms on patients’ overall well-being.  
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Figure legend: 
Figure 1 – Reported bothersomeness of gastrointestinal symptoms in IBS-C and IBS-D 
Figure 2. Impact of IBS symptoms on daily living: rates reporting impairment in each category as a result 
of symptoms in IBS-C and IBS-D 
Figure 3. “What would you be willing to give up for one month to have one month of symptom relief?”. 
Rates reporting willingness to give up each item in exchange for one month of symptom relief in IBS-C 
and IBS-D. 
 
  
Table 1 – Survey questions used to assess impact of IBS on daily living 
Question 
Response 
Options 
Productivity 
 
In a typical month, how many days, if any, do these symptoms interfere with your 
productivity (your ability to perform at work or school)? 
Open 
input 
number 
Days Missed From Work or School 
About how many days, if any, in a typical month do you miss work or school because of 
your gastrointestinal symptoms? 
Open 
input 
number 
Participation in Personal Activities 
In a typical month, how many days, if any, do these symptoms interfere with your ability to 
participate in a personal activity (party, sporting event, family activity, etc.)? 
Open 
input 
number 
Specific Activities 
 My symptoms prevent me from enjoying my daily activities ** 
My symptoms make me feel self-conscious about how I look ** 
My symptoms make me feel “not normal” ** 
I have avoided sex because of my symptoms ** 
I have been told  that I don’t seem accused of not seeming attentive, supportive or 
engaged when suffering from my symptoms ** 
It is difficult to plan things as I never know when my symptoms will act up ** 
My symptoms cause me to travel less ** 
I spend less time with my family and friends as a result of my symptoms ** 
I avoid situations where there won't be a nearby bathroom ** 
I don't feel like myself ** 
I feel like my symptoms prevent me from reaching my full potential/being successful ** 
Trade-Offs  
What, if anything, would you give up for one month to experience one month of relief from 
your gastrointestinal symptoms?  
 1. drinking caffeinated beverages Yes/No 
2. drinking alcohol Yes/No 
3. the internet Yes/No 
4. sex Yes/No 
5. cell phone Yes/No 
** Response options: strongly agree, somewhat agree, somewhat disagree, or strongly disagree 
 
 
 
Table 2 - Demographics 
Characteristics IBS-C IBS-D 
  n = 1667 n = 1587 
Gender (%) 
       Male 19 18.5 
     Female 81 81.5 
Age (average years, SD) 47.92 (14.93) 46.7 (15.34) 
Race (%) 
       White/Caucasian 89 92 
     Hispanic 5 4 
     Black 5 2 
     American Indian 2 2 
     Asian 2 2 
     Other 1 0 
Education (%) 
       High school or less 17 14 
     Some college 44 40 
     College 39 46 
Marital Status (%) 
       Married 65 65 
     Widowed 4 4 
     Divorced 14 14 
     Single 17 17 
Employment (%) 
       Employed 46 50 
     Self-employed 8 6 
     Temporarily unemployed 5 6 
     Full-time student 3 2 
     Full-time homemaker 15 16 
     Retired 21 19 
Median Income $68.52K $69.62K 
 
 
  
Table 3 - Symptoms Experienced in the past year 
 “Which of the following symptoms have you experienced in the past 12 months?” 
IBS-C (n = 1667)   
 
Abdominal pain 83% 
 
Bloating 78% 
 
Straining 75% 
 
Infrequent stools 73% 
 
Hard lumpy stools 72% 
 
Nausea 46% 
   IBS-D (n = 1587)   
 
Abdominal pain 93% 
 
Loose watery stools 89% 
 
Cramping 84% 
 
Frequency of bowel movements 81% 
 
Urgency 77% 
 
Bloating 69% 
 
Loss of bowel control/fecal incontinence 32% 
 
 
 



What you need to know 
Background: We investigated the effects of irritable bowel syndrome (IBS) on daily function and 
compared these among disease subtypes. 
Findings: Although the perceived impact of IBS symptoms on productivity are similar in IBS-C and IBS-D 
subtypes, individuals with IBS-C and IBS-D report differences in specific areas of daily functioning. 
Implications for patient care: This study highlights important differences between IBS-C and IBS-D, which 
could impact the development and refinement of mind-body therapies for IBS, with tailored treatment 
goals for each IBS subtype. 
Supplementary materials 
Supplementary Table 1. Multivariate analyses of the impact of IBS on daily life. Each analysis controls 
for subtype (IBS-C vs. IBS-D), employment status (employed/student vs. unemployed), age, sex 
(male/female), and symptom bothersomeness 
Because of my symptoms, I have avoided: 
 OR CI p-value 
Situations where there won’t be a bathroom 
IBS-C 0.338 0.285 0.401 <0.001 
Employed 0.796 0.665 0.954 0.014 
Age 1.003 0.997 1.009 0.270 
Female 0.861 0.696 1.066 0.169 
Symptom bothersome 2.049 1.862 2.254 <0.001 
Making plans 
IBS-C 0.627 0.535 0.735 <0.001 
Employed 0.719 0.606 0.853 <0.001 
Age 0.999 0.993 1.004 0.687 
Female 0.937 0.766 1.145 0.524 
Symptom bothersome 2.776 2.520 3.059 <0.001 
Leaving the house 
IBS-C 0.716 0.612 0.839 <0.001 
Employed 0.542 0.456 0.644 <0.001 
Age 0.989 0.984 0.995 <0.001 
Female 0.992 0.813 1.212 0.940 
Symptom bothersome 2.718 2.467 2.993 <0.001 
Sex 
IBS-C 1.451 1.238 1.702 <0.001 
Employed 0.967 0.812 1.150 0.702 
Age 0.977 0.972 0.983 <0.001 
Female 1.667 1.367 2.033 <0.001 
Symptom bothersome 1.679 1.536 1.834 <0.001 
My symptoms prevent me from: 
 OR CI p-value 
Enjoying daily activities 
IBS-C 1.00 0.850 1.176 0.995 
Employed 0.686 0.574 0.819 <0.001 
Age 0.996 0.991 1.002 0.222 
Female 0.859 0.697 1.059 0.154 
Symptom bothersome 3.168 2.856 3.514 <0.001 
Traveling 
IBS-C 0.705 0.602 0.825 <0.001 
Employed 0.660 0.557 0.783 <0.001 
Age 0.994 0.989 1.000 0.039 
Female 0.706 0.577 0.863 0.001 
Symptom bothersome 2.705 2.457 2.977 <0.001 
Reaching potential 
IBS-C 1.158 0.990 1.356 0.067 
Employed 0.782 0.659 0.927 0.005 
Age 0.987 0.982 0.992 <0.001 
Female 0.860 0.703 1.052 0.143 
Symptom bothersome 2.840 2.577 3.129 <0.001 
Spending time with family and friends 
IBS-C 0.898 0.769 1.049 0.174 
Employed 0.800 0.676 0.946 0.009 
Age 0.996 0.991 1.002 0.171 
Female 0.708 0.580 0.864 0.001 
Symptom bothersome 2.629 2.393 2.888 <0.001 
Concentrating on tasks 
IBS-C 1.287 1.098 1.508 0.002 
Employed 0.941 0.791 1.118 0.488 
Age 0.978 0.973 0.984 <0.001 
Female 0.606 0.496 0.741 <0.001 
Symptom bothersome 1.958 1.786 2.146 <0.001 
My symptoms make me feel 
 OR CI p-value 
Not normal 
IBS-C 0.979 0.830 1.155 0.799 
Employed 0.931 0.778 1.114 0.435 
Age 0.990 0.984 0.996 0.001 
Female 1.140 0.924 1.406 0.223 
Symptom bothersome 2.444 2.213 2.699 <0.001 
Self-conscious 
IBS-C 1.554 1.334 1.809 <0.001 
Employed 1.168 0.990 1.377 0.066 
Age 0.982 0.976 0.987 <0.001 
Female 1.535 1.262 1.867 <0.001 
Symptom bothersome 1.945 1.783 2.122 <0.001 
Not like myself 
IBS-C 1.507 1.277 1.778 <0.001 
Employed 0.88 0.734 1.055 0.167 
Age 1.006 1.000 1.012 0.045 
Female 1.291 1.050 1.587 0.015 
Symptom bothersome 2.274 2.063 2.507 <0.001 
 
 
 
 
 
 
Supplementary Table 2. Univariate analyses in each specific area of daily living 
Because of my symptoms, I have avoided 
 Yes No p 
Situations where there won’t be a bathroom    
Subtype   p=0.000 
IBS-C (1618) 63% 37%  
IBS-D (1572) 81% 19%  
Employment   p=0.000 
Employed/student (1852) 69% 31%  
Not employed (1338) 75% 25%  
Sex   p=0.425 
Female (2587) 72% 28%  
Male (603) 73% 27%  
Average age (SD) 47.4 (15.0) 47.1 (15.5) p=0.548 
Symptom bothersomeness   p=0.000 
Not at all (14) 21% 79%  
A little (354) 47% 53%  
Somewhat (1156) 66% 34%  
Very (1081) 79% 21%  
Extremely (585) 86% 14%  
Making plans    
Subtype   p=0.000 
IBS-C (1611) 57% 43%  
IBS-D (1564) 65% 35%  
Employment   p=0.000 
Employed/student (1839) 58% 42%  
Not employed (1336) 66% 34%  
Sex   p=0.830 
Female (2579) 61% 39%  
Male (596) 61% 39%  
Average age (SD) 47.2 (14.8) 47.5 (15.8) p=0.490 
Symptom bothersomeness   p=0.000 
Not at all (14) 21% 79%  
A little (346) 25% 75%  
Somewhat (1148) 49% 51%  
Very (1079) 72% 28%  
Extremely (588) 88% 12%  
Leaving the house    
Subtype   p=0.001 
IBS-C (1627) 59% 41%  
IBS-D (1555) 64% 36%  
Employment   p=0.000 
Employed/student (1844) 56% 44%  
Not employed (1338) 69% 31%  
Sex   p=0.203 
Female (2584) 62% 38%  
Male (598) 59% 41%  
Average age (SD) 46.6 (14.7) 48.2 (15.8) p=0.005 
Symptom bothersomeness   p=0.000 
Not at all (14) 7% 93%  
A little (347) 26% 74%  
Somewhat (1150) 50% 50%  
Very (1084) 70% 30%  
Extremely (587) 89% 11%  
Sex    
Subtype   p=0.000 
IBS-C (1416) 64% 36%  
IBS-D (1367) 55% 45%  
Employment   p=0.660 
Employed/student (1687) 60% 40%  
Not employed (1096) 59% 41%  
Sex   p=0.000 
Female (2227) 62% 48%  
Male (556) 50% 50%  
Average age (SD) 44.2 (14.0) 49.2 (15.5) p=0.000 
Symptom bothersomeness   p=0.000 
Not at all (14) 29% 71%  
A little (312) 46% 54%  
Somewhat (990) 50% 50%  
Very (949) 65% 35%  
Extremely (518) 78% 22%  
my symptoms prevent me from: 
 Yes No p 
Enjoying daily activities    
Subtype   p=0.455 
IBS-C (1639) 66% 34%  
IBS-D (1566) 65% 35%  
Employment   p=0.000 
Employed/student (1854) 62% 38%  
Not employed (1351) 71% 30%  
Sex   p=0.647 
Female (2603) 66% 34%  
Male (602) 66% 34%  
Average age (SD) 47.1 (14.9) 47.7 (15.5) p=0.250 
Symptom bothersomeness   p=0.000 
Not at all (14) 29% 71%  
A little (350) 26% 74%  
Somewhat (1162) 48% 52%  
Very (1090) 21% 79%  
Extremely (589) 8% 92%  
Traveling    
Subtype   p=0.001 
IBS-C (1579) 54% 46%  
IBS-D (1518) 60% 40%  
Employment   p=0.000 
Employed/student (1808) 53% 47%  
Not employed (1289) 62% 38%  
Sex   p=0.034 
Female (2507) 56% 44%  
Male (590) 61% 39%  
Average age (SD) 46.8 (14.7) 47.8 (15.8)  p=0.060 
Symptom bothersomeness   p=0.000 
Not at all (14) 14% 86%  
A little (336) 22% 78%  
Somewhat (1119) 44% 56%  
Very (1059) 66% 34%  
Extremely (569) 86% 14%  
Reaching potential    
Subtype   p=0.027 
IBS-C (1573) 58% 42%  
IBS-D (1514) 54% 46%  
Employment   p=0.008 
Employed/student (1817) 54% 46%  
Not employed (1270) 58% 42%  
Sex   p=0.560 
Female (2500) 55% 45%  
Male (587) 57% 43%  
Average age (SD) 45.9 (14.7) 48.5 (15.4) p=0.000 
Symptom bothersomeness   p=0.000 
Not at all (14) 21% 79%  
A little (340) 20% 80%  
Somewhat (1109) 41% 59%  
Very (1055) 67% 33%  
Extremely (569) 86% 14%  
Spending time with family and friends    
Subtype   p=0.477 
IBS-C (1591) 40% 60%  
IBS-D (1536) 42% 58%  
Employment   p=0.001 
Employed/student (1816) 38% 62%  
Not employed (1311) 45% 55%  
Sex   p=0.022 
Female (2540) 40% 60%  
Male (587) 45% 55%  
Average age (SD) 46.8 (14.7) 47.6 (15.4) p=0.110 
Symptom bothersomeness   p=0.000 
Not at all (14) 7% 93%  
A little (341) 12% 88%  
Somewhat (1133) 27% 73%  
Very (1062) 48% 52%  
Extremely (577) 73% 27%  
Concentrating on tasks    
Subtype   p=0.001 
IBS-C (1479) 43% 57%  
IBS-D (1395) 37% 63%  
Employment   p=0.252 
Employed/student (1719) 41% 59%  
Not employed (1155) 39% 61%  
Sex   p=0.000 
Female (2318) 38% 62%  
Male (556) 49% 51%  
Average age (SD) 44.2 (14.4) 48.7 (15.2) p=0.000 
Symptom bothersomeness   p=0.000 
Not at all (12) 8% 92%  
A little (308) 17% 83%  
Somewhat (1036) 31% 69%  
Very (993) 47% 53%  
Extremely (525) 62% 38%  
my symptoms make me feel 
 Yes No p 
Not normal    
Subtype   p=0.000 
IBS-C (1631) 72% 28%  
IBS-D (1549) 72% 28%  
Employment   p=0.287 
Employed/student (1845) 71% 29%  
Not employed (1335) 73% 27%  
Sex   p=0.135 
Female (2592) 73% 27%  
Male (588) 69% 31%  
Average age (SD) 46.6 (14.5) 49.1 (15.6) p=0.000 
Symptom bothersomeness   p=0.000 
Not at all (13) 23% 77%  
A little (346) 39% 61%  
Somewhat (1147) 64% 36%  
Very (1087) 81% 19%  
Extremely (587) 90% 10%  
Self-conscious    
Subtype   p=0.000 
IBS-C (1588) 64% 36%  
IBS-D (1513) 54% 46%  
Employment   p=0.018 
Employed/student (1809) 61% 39%  
Not employed (1292) 57% 43%  
Sex   p=0.000 
Female (2525) 61% 39%  
Male (576) 51% 49%  
Average age (SD) 45.2 (14.9) 49.8 (15.0) p=0.000 
Symptom bothersomeness   p=0.000 
Not at all (13) 31% 69%  
A little (342) 37% 63%  
Somewhat (1116) 48% 52%  
Very (1056) 66% 34%  
Extremely (574) 80% 20%  
Not like myself    
Subtype   p=0.000 
IBS-C (1625) 76% 24%  
IBS-D (1540) 68% 32%  
Employment   p=0.000 
Employed/student (1835) 70% 30%  
Not employed (1330) 76% 24%  
Sex   p=0.006 
Female (2569) 73% 27%  
Male (596) 68% 32%  
Average age (SD) 47.5 (15.0) 46.5 (15.2) p=0.089 
Symptom bothersomeness   p=0.000 
Not at all (13) 31% 70%  
A little (350) 45% 55%  
Somewhat (1139) 64% 36%  
Very (1078) 80% 20%  
Extremely (585) 91% 9%  
 
 
 
 
